Latest Breaking News On - Department of dermatology at mount sinai medicine - Page 1 : comparemela.com

The small-molecule oral investigational agent JNJ-77242113 at the highest dose tested was associated with reductions in psoriasis severity comparable to injectable biologic agents.

New yorkUnited statesUniversity of pennsylvaniaMarkg lebwohlJoelm gelfandRobert bissonnetteIcahn school of medicine at mount sinaiDepartment of dermatology at mount sinai medicineInnovaderm researchPsoriasis areaSeverity indexNew england journalMedscape medical newsClinical therapeuticsIcahn schoolMount sinai